The Wall Street Journal130d agoneutral
The Latest Senior-Citizen Special Is Here: Cheap Weight-Loss DrugsNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Investor's Business Daily135d agoneutral
Nike Stock Languishes, But Looming Earnings Report Fuels Turnaround OptimismInsider Monkey135d agoneutral
Eli Lilly (LLY) Acquires Centessa Pharmaceuticals to Advance Orexin Receptor 2 AgonistsInsider Monkey137d agoneutral
Is Eli Lilly and Company (LLY) Strengthening Its Pain Management Strategy With New Biotech Acquisition?The Wall Street Journal139d agoneutral
When Diets Don’t Work: Parents Turn to Wegovy for Elementary School KidsMotley Fool141d agoneutral
Lilly's 7 Acquisitions in 3 Months: Which Will Be the Biggest Game-Changer for the Pharma Giant?Insider Monkey144d agoneutral
FDA Approves New Eight-Week Maintenance Dosing Regimen for Eli Lilly’s (LLY) EBGLYSSReuters Videos144d agoneutralVIDEO
Big pharma taps UK playbook to pressure Europe on drug pricesThe Wall Street Journal153d agoneutral
Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial SuccessStockStory153d agoneutral
Q1 Earnings Review: Branded Pharmaceuticals Stocks Led by Eli Lilly (NYSE:LLY)The Wall Street Journal154d agoneutral
Your Weight-Loss Drugs Are Next on the Corporate Chopping Block